Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hand Advisory Committee); Notice of Meeting, 24449-24450 [05-9232]

Download as PDF Federal Register / Vol. 70, No. 88 / Monday, May 9, 2005 / Notices Dated: May 4, 2005. Debbie Powell, Director, Office of Operations and Discretionary Grant Programs, Administration on Developmental Disabilities. [FR Doc. 05–9225 Filed 5–6–05; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2000P–1439] (formerly Docket No. 00P–1439) Iceberg Industries Corp.; Revocation of Temporary Permit for Market Testing AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the revocation of a temporary permit issued to Iceberg Industries Corp. to market test products designated as ‘‘Borealis Iceberg Water’’ because there is no evidence that the company is operational, and the need for the permit no longer exists. FOR FURTHER INFORMATION CONTACT: Loretta Carey, Center for Food Safety and Applied Nutrition (HFS–820), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301–436–2371. SUPPLEMENTARY INFORMATION: In a notice published in the Federal Register of September 7, 2000 (65 FR 54283), FDA issued a temporary permit to Iceberg Industries Corp., 16 Forest Rd., suite 300, St. John’s, Newfoundland, Canada, A1C2B9, to market test products identified as ‘‘iceberg water,’’ a name that is not permitted under the U.S. standard of identity for bottled water in § 165.110 (21 CFR 165.110). The agency issued the permit to facilitate market testing of products whose labeling differs from the requirements of the standard of identity for bottled water issued under section 401 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 341). The permit covered limited interstate market testing of products that deviated from the standard for bottled water in § 165.110 in that they were identified as ‘‘iceberg water’’ rather than as ‘‘bottled water’’ or one of the other names specified in § 165.110(a)(2). The test product met all the requirements of the standard with the exception of this deviation. On September 28, 2001, Iceberg Industries Corp. requested that its temporary permit be extended to allow VerDate jul<14>2003 17:20 May 06, 2005 Jkt 205001 for additional time for the market testing of its products under the permit in order to gain additional information in support of its petition. In the Federal Register of June 27, 2002 (67 FR 43325), FDA announced that it was extending the temporary permit issued to Iceberg Industries Corp. to market test products designated as ‘‘Borealis Iceberg Water.’’ The extension allowed the permit holder to continue to collect data on consumer acceptance of products while the agency considered the petition to amend the standard of identity for bottled water, which was submitted by the permit holder. Under the extension, FDA invited interested persons to participate in the market test under the conditions that applied to Iceberg Industries Corp., except for the designated area of distribution. No one accepted the invitation to participate in the market test. In March 2004, FDA attempted to contact Iceberg Industries Corp. to discuss some issues regarding its petition at the telephone number listed in its petition. The telephone number was no longer in service. Attempts to reach the applicant by letter were unsuccessful. Therefore, under 21 CFR 130.17(g)(3), FDA is revoking the Iceberg Industries Corp.’s temporary permit because the need no longer exists. Dated: May 3, 2005. Barbara Schneeman, Director, Office of Nutritional Products, Labeling and Dietary Supplements, Center for Food Safety and Applied Nutrition. [FR Doc. 05–9233 Filed 5–6–05; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Drug Safety and Risk Management Advisory Committee; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Drug Safety and Risk Management Advisory Committee. This meeting was announced in the Federal Register of April 14, 2005 (70 FR 19763). The amendment is being made to reflect a change in the Date and Time portion of the document. The start time for each day of the meeting will be changed. There are no other changes. PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 24449 FOR FURTHER INFORMATION CONTACT: Shalini Jain, Center for Drug Evaluation and Research (HFD–21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301–827– 7001, FAX: 301–827–6776, e-mail: jains@cder.fda.gov, or FDA Advisory Committee Information Line, 1–800– 741–8138 (301–443–0572 in the Washington DC area), code 3014512535. Please call the Information Line for upto-date information on this meeting. SUPPLEMENTARY INFORMATION: In the Federal Register of April 14, 2005, FDA announced that a meeting of the Drug Safety and Risk Management Advisory Committee would be held on May 18 and 19, 2005, from 8:30 a.m. to 5 p.m. On page 19763, in the third column, the Date and Time portion of the meeting notice is amended to read as follows: Date and Time: The meeting will be held on May 18 and 19, 2005, from 8 a.m. to 5 p.m. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees. Dated: May 3, 2005. Lester M. Crawford, Acting Commissioner of Food and Drugs. [FR Doc. 05–9228 Filed 5–6–05; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committee on Special Studies Relating to the Possible LongTerm Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hand Advisory Committee); Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hand Advisory Committee). General Function of the Committee: To advise the Secretary of Health and Human Services (the Secretary) and the Assistant Secretary for Health concerning its oversight of the conduct of the Ranch Hand study by the U.S. Air E:\FR\FM\09MYN1.SGM 09MYN1 24450 Federal Register / Vol. 70, No. 88 / Monday, May 9, 2005 / Notices Force and provide scientific oversight of the Department of Veterans Affairs Army Chemical Corps Vietnam Veterans Health Study, and other studies in which the Secretary or the Assistant Secretary for Health believes involvement by the committee is desirable. Date and Time: The meeting will be held on June 10, 2005, from 8:30 a.m. to 4 p.m. Location: Food and Drug Administration, 5630 Fishers Lane, rm. 1066, Rockville, MD. Contact Person: Leonard Schechtman, National Center for Toxicological Research (HFT–10), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–6696, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512560. Please call the Information Line for up-to-date information on this meeting. Agenda: The committee will discuss the following items: (1) Updates on research and reports from the National Academy of Sciences (NAS) on the NAS Disposition Study, (2) April 14th public workshop regarding the NAS Disposition Study, (3) discussion on the possibility of a comprehensive study report derived from the Air Force Health Study (AFHS), and (4) research updates on AFHS activities. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by May 20, 2005. Oral presentations from the public will be scheduled between approximately 10:45 a.m. and 11:45 a.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before May 20, 2005, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Leonard Schechtman at least 7 days in advance of the meeting. VerDate jul<14>2003 17:20 May 06, 2005 Jkt 205001 Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). DEPARTMENT OF INTERIOR Dated: April 29, 2005. Sheila Dearybury Walcoff, Associate Commissioner for External Relations. [FR Doc. 05–9232 Filed 5–6–05; 8:45 am] DEPARTMENT OF COMMERCE BILLING CODE 4160–01–S Office of the Secretary Delaware & Lehigh National Heritage Corridor Commission Meeting Department of Interior, Office of the Secretary. AGENCY: Notice of meeting. SUMMARY: This notice announces an upcoming meeting of the Delaware & Lehigh National Heritage Corridor Commission. Notice of this meeting is required under the Federal Advisory Committee Act (Pub. L. 92–463). Meeting Date and Time: Friday, May 13, 2005, 1:30 p.m. to 4 p.m. Emmaus Public Library, 11 Main Street, Emmaus, PA 18049. The agenda for the meeting will focus on implementation of the Management Action Plan for the Delaware and Lehigh National Heritage Corridor and State Heritage Park. The Commission was established to assist the Commonwealth of Pennsylvania and its political subdivisions in planning and implementing an integrated strategy for protecting and promoting cultural, historic and natural resources. The Commission reports to the Secretary of the Interior and to Congress. ADDRESSES: The Delaware & Lehigh National Heritage Corridor Commission was established by Public Law 100–692, November 18, 1988 and extended through Public Law 105–355, November 13, 1998. SUPPLEMENTARY INFORMATION: C. Allen Sachse, Executive Director, Delaware & Lehigh National Heritage Corridor Commission, 1 South Third Street, 8th Floor, Easton, PA 18042, (610) 923–3548. FOR FURTHER INFORMATION CONTACT: Dated: May 2, 2005. C. Allen Sachse, Executive Director, Delaware & Lehigh National Heritage Corridor Commision. [FR Doc. 05–9176 Filed 5–6–05; 8:45 am] BILLING CODE 6820–PE–M PO 00000 Frm 00085 Fmt 4703 National Oceanic and Atmospheric Administration, National Marine Fisheries Service [I.D. 041205C] DEPARTMENT OF THE INTERIOR ACTION: Fish and Wildlife Service Sfmt 4703 Notice of Intent to Conduct Public Scoping Meetings and to Prepare an Environmental Impact Statement Related to the Elliott State Forest Habitat Conservation Plan Fish and Wildlife Service (FWS), Interior; National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration, Commerce. ACTION: Notice of intent, to conduct scoping meetings. AGENCIES: SUMMARY: The U.S. Fish and Wildlife Service and National Marine Fisheries Service (Services) advise interested parties of their intent to conduct public scoping under the National Environmental Policy Act (NEPA) necessary to gather information to prepare an Environmental Impact Statement (EIS) on an anticipated permit application from the Oregon Division of Forestry (ODF) submitted under of the Endangered Species Act (ESA) for the incidental take of listed species, associated with the Elliott State Forest Habitat Conservation Plan (HCP) in Oregon. DATES: Public scoping meetings are scheduled as follows: 1. May 24, 2005, 6–10 p.m., Roseburg, OR. 2. May 25, 2005, 6–10 p.m., North Bend, OR. 3. May 26, 2005, 6–10 p.m., Salem, OR. Written comments should be received on or before June 8, 2005. ADDRESSES: All comments concerning the preparation of the EIS and the NEPA process should be addressed to: Lee Folliard, FWS, 2600 SE 98th Avenue, Suite 100, Portland, OR 97266, facsimile: (503) 231–6195; or Chuck Wheeler, NMFS, 2900 NW Stewart Parkway, Roseberg, OR 97470–1274, facsimile: (541) 957–3386. FOR FURTHER INFORMATION CONTACT: Lee Folliard, (503) 231–6179 or Chuck Wheeler (541) 957–3379. Comments may be submitted by e-mail to the following address: ElliottStateForest.nwr@noaa.gov. In the subject line of the e-mail, include the document identifier: Elliott State Forest E:\FR\FM\09MYN1.SGM 09MYN1

Agencies

[Federal Register Volume 70, Number 88 (Monday, May 9, 2005)]
[Notices]
[Pages 24449-24450]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9232]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee on Special Studies Relating to the Possible 
Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch 
Hand Advisory Committee); Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Advisory Committee on Special Studies Relating 
to the Possible Long-Term Health Effects of Phenoxy Herbicides and 
Contaminants (Ranch Hand Advisory Committee).
    General Function of the Committee: To advise the Secretary of 
Health and Human Services (the Secretary) and the Assistant Secretary 
for Health concerning its oversight of the conduct of the Ranch Hand 
study by the U.S. Air

[[Page 24450]]

Force and provide scientific oversight of the Department of Veterans 
Affairs Army Chemical Corps Vietnam Veterans Health Study, and other 
studies in which the Secretary or the Assistant Secretary for Health 
believes involvement by the committee is desirable.
    Date and Time: The meeting will be held on June 10, 2005, from 8:30 
a.m. to 4 p.m.
    Location: Food and Drug Administration, 5630 Fishers Lane, rm. 
1066, Rockville, MD.
    Contact Person: Leonard Schechtman, National Center for 
Toxicological Research (HFT-10), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-6696, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 3014512560. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: The committee will discuss the following items: (1) Updates 
on research and reports from the National Academy of Sciences (NAS) on 
the NAS Disposition Study, (2) April 14th public workshop regarding the 
NAS Disposition Study, (3) discussion on the possibility of a 
comprehensive study report derived from the Air Force Health Study 
(AFHS), and (4) research updates on AFHS activities.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by May 20, 2005. 
Oral presentations from the public will be scheduled between 
approximately 10:45 a.m. and 11:45 a.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before May 20, 2005, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Leonard Schechtman 
at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 29, 2005.
Sheila Dearybury Walcoff,
Associate Commissioner for External Relations.
[FR Doc. 05-9232 Filed 5-6-05; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.